Charlotte, North Carolina

Charlotte, North Carolina 28211-4849

0 studies enrolling now · 2 studies all time

What they study most

Schizophrenia

Studies at this site

• A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia — Completed
• A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia — Completed